HUMANA INC false 0000049071 0000049071 2021-08-03 2021-08-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 3, 2021 (August 3, 2021)

 

 

Humana Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-05975   61-0647538

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

500 W. Main Street, Louisville, Kentucky 40202

(Address of Principal Executive Offices, and Zip Code)

(502) 580-1000

Registrant’s Telephone Number, Including Area Code

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock   HUM   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 1.01.

Entry into a Material Definitive Agreement.

On August 3, 2021, Humana Inc. (the “Company”) completed a public offering of $1,500 million aggregate principal amount of its 0.650% Senior Notes due 2023 (the “2023 Senior Notes”), $750 million aggregate principal amount of its 1.350% Senior Notes due 2027 (the “2027 Senior Notes”) and $750 million aggregate principal amount of its 2.150% Senior Notes due 2032 (the “2032 Senior Notes” and, together with the 2023 Senior Notes and the 2027 Senior Notes, the “Senior Notes”). The Senior Notes were issued under an indenture dated as of August 5, 2003, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the “Trustee”) (the “Original Indenture”), as supplemented by an eighteenth supplemental indenture, dated as of August 3, 2021, by and between the Company and the Trustee relating to the 2023 Senior Notes (the “Eighteenth Supplemental Indenture” and, together with the Original Indenture, the “Eighteenth Indenture”), a nineteenth supplemental indenture, dated as of August 3, 2021, by and between the Company and the Trustee relating to the 2027 Senior Notes (the “Nineteenth Supplemental Indenture” and, together with the Original Indenture, the “Nineteenth Indenture”) and a twentieth supplemental indenture, dated as of August 3, 2021, by and between the Company and the Trustee relating to the 2032 Senior Notes (the “Twentieth Supplemental Indenture” and, together with the Original Indenture, the “Twentieth Indenture,” and the Eighteenth Indenture, Nineteenth Indenture and Twentieth Indenture are referred to herein as the “Indentures”).

Pursuant to the terms of each of the Indentures, the Senior Notes are unsecured senior obligations of the Company and rank equally with all of the Company’s other unsecured, unsubordinated indebtedness. The 2023 Senior Notes bear interest at an annual rate of 0.650%, the 2027 Senior Notes bear interest at an annual rate of 1.350% and the 2032 Senior Notes bear interest at an annual rate of 2.150%. Interest on the Senior Notes is payable by the Company on February 3 and August 3 of each year, beginning on February 3, 2022. The 2023 Senior Notes mature on August 3, 2023, the 2027 Senior Notes mature on February 3, 2027 and the 2032 Senior Notes mature on February 3, 2032.

A copy of the Original Indenture is filed as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Eighteenth Supplemental Indenture is filed as Exhibit 4.2 to this Current Report on Form 8-K and is incorporated by reference herein. The form of 2023 Senior Notes is filed as Exhibit 4.3 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Nineteenth Supplemental Indenture is filed as Exhibit 4.4 to this Current Report on Form 8-K and is incorporated by reference herein. The form of 2027 Senior Notes is filed as Exhibit 4.5 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Twentieth Supplemental Indenture is filed as Exhibit 4.6 to this Current Report on Form 8-K and is incorporated by reference herein. The form of 2032 Senior Notes is filed as Exhibit 4.7 to this Current Report on Form 8-K and is incorporated by reference herein. The descriptions of the material terms of the Original Indenture, the Eighteenth Supplemental Indenture, the 2023 Senior Notes, the Nineteenth Supplemental Indenture, the 2027 Senior Notes, the Twentieth Supplemental Indenture and the 2032 Senior Notes are qualified in their entirety by reference to such exhibits. In addition, the legal opinion of Fried, Frank, Harris, Shriver & Jacobson LLP related to the Senior Notes is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The Trustee has also been appointed registrar and paying agent with regard to the Senior Notes and serves the same roles with respect to certain other series of the Company’s outstanding senior notes. An affiliate of the Trustee is also a lender under the Company’s existing credit facility.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure above under Item 1.01 of this Current Report on Form 8-K is also responsive to Item 2.03 of this Current Report on Form 8-K and is incorporated by reference into this Item 2.03.

 

Item 7.01.

Regulation FD Disclosure.

The Company issued a press release announcing the closing of the offering of the Senior Notes, which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.


None of the information furnished in this Item 7.01 hereto (including Exhibit 99.1) shall be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this Item 7.01 (including Exhibit 99.1) shall be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit No.   

Description

4.1    Indenture, dated as of August 5, 2003, by and between the Company and The Bank of New York, as trustee (incorporated herein by reference to Exhibit 4.1 to Humana Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003).
4.2    Eighteenth Supplemental Indenture, dated August 3, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee.
4.3    Form of 0.650% Senior Notes due 2023.
4.4    Nineteenth Supplemental Indenture, dated August 3, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee.
4.5    Form of 1.350% Senior Notes due 2027.
4.6    Twentieth Supplemental Indenture, dated August 3, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee.
4.7    Form of 2.150% Senior Notes due 2032.
5.1    Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP.
23.1    Consent of Fried, Frank, Harris, Shriver & Jacobson LLP (See Exhibit 5.1).
99.1    Press Release relating to the closing of the offering of Senior Notes, dated August 3, 2021, issued by the Company.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HUMANA INC.
BY:  

/s/ Cynthia H. Zipperle

  Cynthia H. Zipperle
  Senior Vice President, Chief Accounting Officer and Controller
  (Principal Accounting Officer)

Dated: August 3, 2021

Humana (NYSE:HUM)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Humana Charts.
Humana (NYSE:HUM)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Humana Charts.